Source:http://linkedlifedata.com/resource/pubmed/id/16580698
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0003402,
umls-concept:C0014272,
umls-concept:C0017262,
umls-concept:C0026336,
umls-concept:C0034693,
umls-concept:C0034721,
umls-concept:C0087111,
umls-concept:C0185117,
umls-concept:C0205191,
umls-concept:C1421314,
umls-concept:C1522564,
umls-concept:C1948023,
umls-concept:C1998811,
umls-concept:C2911684
|
pubmed:issue |
25
|
pubmed:dateCreated |
2006-5-8
|
pubmed:abstractText |
Excessive beta-adrenergic stimulation causes cardiac toxicity, which also contributes to cardiac oxidative stress. Although uncoupling protein 2 (UCP2), a member of the mitochondrial inner membrane carrier family, can regulate energy efficiency and oxidative stress in mitochondria, little data exist regarding interactions between UCP2 expression and beta-adrenergic stimulation induced cardiac oxidative damage. We investigated whether chronic beta-adrenergic stimulation induces myocardial energy metabolism abnormality via oxidative stress, including any role of UCP2. We also examined whether 3-methyl-1-phenyl-2-pyrazolin-5-one (MIC-186; edaravone), a potent free radical scavenger, has cardioprotective effects against beta-adrenergic stimulation. Male Sprague-Dawley rats received isoproterenol (1.2 mg/kg/day) subcutaneously or/and edaravone (30 mg/kg/day) orally. Isoproterenol increased the heart/body weight ratio, accompanied by an increase in the level of myocardial thiobarbituric acid reactive substances (TBARS) and a decreased phosphocreatine (PCr) to adenosine triphosphate (ATP) ratio. Isoproterenol also markedly increased expressions of UCP2 mRNA (1.74 fold vs. non-isoproterenol) and protein (1.93 fold vs. non-isoproterenol). Edaravone had no apparent effect in hypertrophic responses, but significantly prevented both increases in TBARS and decreases in the PCr/ATP ratio. Edaravone also prevented increases in UCP2 mRNA (0.76 fold vs. isoproterenol) and protein (0.62 fold vs. isoproterenol) expressions against isoproterenol administration. Our results suggest that chronic beta-adrenergic stimulation induces myocardial energy inefficiency via excessive oxidative stress. The antioxidant effect of edaravone has potential to improve energy metabolism abnormalities against beta-adrenergic stimulation. Adequate regulation of UCP2 expression through artificial reduction of oxidative stress may play an important role in protection of the myocardial energy metabolism.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Agonists,
http://linkedlifedata.com/resource/pubmed/chemical/Antioxidants,
http://linkedlifedata.com/resource/pubmed/chemical/Antipyrine,
http://linkedlifedata.com/resource/pubmed/chemical/Cardiotonic Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Ion Channels,
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Transport Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Mitochondrial Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/mitochondrial uncoupling protein 2,
http://linkedlifedata.com/resource/pubmed/chemical/phenylmethylpyrazolone
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0024-3205
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
78
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2974-82
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16580698-Adrenergic beta-Agonists,
pubmed-meshheading:16580698-Animals,
pubmed-meshheading:16580698-Antioxidants,
pubmed-meshheading:16580698-Antipyrine,
pubmed-meshheading:16580698-Cardiotonic Agents,
pubmed-meshheading:16580698-Energy Metabolism,
pubmed-meshheading:16580698-Hemodynamics,
pubmed-meshheading:16580698-Ion Channels,
pubmed-meshheading:16580698-Lipid Peroxidation,
pubmed-meshheading:16580698-Male,
pubmed-meshheading:16580698-Membrane Transport Proteins,
pubmed-meshheading:16580698-Mitochondria, Heart,
pubmed-meshheading:16580698-Mitochondrial Proteins,
pubmed-meshheading:16580698-Myocardium,
pubmed-meshheading:16580698-Organ Size,
pubmed-meshheading:16580698-Oxidative Stress,
pubmed-meshheading:16580698-Rats,
pubmed-meshheading:16580698-Rats, Sprague-Dawley
|
pubmed:year |
2006
|
pubmed:articleTitle |
An antioxidant treatment potentially protects myocardial energy metabolism by regulating uncoupling protein 2 expression in a chronic beta-adrenergic stimulation rat model.
|
pubmed:affiliation |
Second Department of Internal Medicine, Kagawa University School of Medicine, Miki, Kita, Kagawa, 761-0793, Japan. mkto@med.kagawa-u.ac.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|